Effect of ramosetron in female patients with irritable bowel syndrome with diarrhea: a phase III long-term study

Background The long-term safety of administration of ramosetron in female patients with irritable bowel syndrome with diarrhea (IBS-D) is unknown. The aim of this study was to assess the long-term safety, tolerability, and outcomes with the use of ramosetron in female patients with IBS-D.